Contaminated drug ingredient found in GSK facility in Ireland

04/2/2014 | Reuters

Contaminated paroxetine, a drug ingredient used to make antidepressant drugs Seroxat and Paxil, was discovered by the FDA at a GlaxoSmithKline facility in Ireland. GSK did not take enough action to resolve the plant's objectionable conditions that were listed by regulators after an October inspection, the FDA said in a March 18 letter. GSK also failed to notify customers about the problem after shipping batches of a drug or drugs with the contaminated ingredient, the agency added. The FDA said that unless the issues are resolved, approval of new-drug applications listing GSK as producer of drug ingredients might be denied and import of drugs produced from the facility might be blocked.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN